Disc Medicine, Inc. (IRON)
NASDAQ: IRON · Real-Time Price · USD
61.10
+2.07 (3.51%)
At close: Aug 13, 2025, 4:00 PM
61.10
0.00 (0.00%)
After-hours: Aug 13, 2025, 4:36 PM EDT

Disc Medicine Statistics

Total Valuation

Disc Medicine has a market cap or net worth of $2.12 billion. The enterprise value is $1.51 billion.

Market Cap 2.12B
Enterprise Value 1.51B

Important Dates

The last earnings date was Thursday, August 7, 2025, before market open.

Earnings Date Aug 7, 2025
Ex-Dividend Date n/a

Share Statistics

Disc Medicine has 34.77 million shares outstanding. The number of shares has increased by 29.27% in one year.

Current Share Class 34.77M
Shares Outstanding 34.77M
Shares Change (YoY) +29.27%
Shares Change (QoQ) +5.10%
Owned by Insiders (%) 1.10%
Owned by Institutions (%) 92.10%
Float 29.07M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 3.33
P/TBV Ratio 3.46
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 32.11, with a Debt / Equity ratio of 0.05.

Current Ratio 32.11
Quick Ratio 31.54
Debt / Equity 0.05
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -70.94

Financial Efficiency

Return on equity (ROE) is -26.36% and return on invested capital (ROIC) is -18.57%.

Return on Equity (ROE) -26.36%
Return on Assets (ROA) -17.95%
Return on Invested Capital (ROIC) -18.57%
Return on Capital Employed (ROCE) -26.19%
Revenue Per Employee n/a
Profits Per Employee -$1.73M
Employee Count 84
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Disc Medicine has paid $461,000 in taxes.

Income Tax 461,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +35.72% in the last 52 weeks. The beta is 2.50, so Disc Medicine's price volatility has been higher than the market average.

Beta (5Y) 2.50
52-Week Price Change +35.72%
50-Day Moving Average 55.53
200-Day Moving Average 54.56
Relative Strength Index (RSI) 61.28
Average Volume (20 Days) 389,689

Short Selling Information

The latest short interest is 2.26 million, so 6.50% of the outstanding shares have been sold short.

Short Interest 2.26M
Short Previous Month 2.83M
Short % of Shares Out 6.50%
Short % of Float 7.77%
Short Ratio (days to cover) 6.54

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -168.76M
Pretax Income -90.89M
Net Income -145.39M
EBITDA -168.64M
EBIT -168.76M
Earnings Per Share (EPS) -$4.53
Full Income Statement

Balance Sheet

The company has $649.97 million in cash and $30.92 million in debt, giving a net cash position of $619.05 million or $17.81 per share.

Cash & Cash Equivalents 649.97M
Total Debt 30.92M
Net Cash 619.05M
Net Cash Per Share $17.81
Equity (Book Value) 614.17M
Book Value Per Share 17.70
Working Capital 640.99M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$134.23 million and capital expenditures -$1.33 million, giving a free cash flow of -$135.56 million.

Operating Cash Flow -134.23M
Capital Expenditures -1.33M
Free Cash Flow -135.56M
FCF Per Share -$3.90
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Disc Medicine does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -29.27%
Shareholder Yield -29.27%
Earnings Yield -6.84%
FCF Yield -6.37%
Dividend Details

Analyst Forecast

The average price target for Disc Medicine is $92.08, which is 50.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target $92.08
Price Target Difference 50.70%
Analyst Consensus Strong Buy
Analyst Count 12
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2